{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:18:22Z","timestamp":1791901102500,"version":"4.3.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatitis C virus (HCV) exists as a heterogenous quasispecies, but the phenotypic consequences of viral variability are widely unexplored. Here we identify a replication enhancing domain (ReED) in non-structural protein 5A conferring high replication fitness to clinical isolates. Accumulation of mutations in the ReED mediates high genome replication capacity. In a cohort of liver transplant patients, high replicator variants are exclusively found in individuals with severe disease outcome, suggesting that high viral replication fitness is associated with increased viral pathogenesis. Analysis of large sequence cohorts reveals that overall only 10% of viral genomes show genetic signatures of high replicators, which are enriched in recipients of liver transplantations, patients developing hepatocellular carcinoma and in HIV coinfected individuals. Overall, our data suggests that low replication fitness is a hallmark of HCV, contributing to establishment of persistence, whereas high replicators appear to have an advantage under conditions of immune suppression, thereby enforcing pathogenesis.<\/jats:p>","DOI":"10.1038\/s41467-025-67174-w","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T09:16:26Z","timestamp":1765098986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-0371","authenticated-orcid":false,"given":"Paul","family":"Rothhaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomke","family":"Arand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Gyu-Thomas","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3854-5288","authenticated-orcid":false,"given":"Margaret","family":"Tulessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4891-7104","authenticated-orcid":false,"given":"Colin","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-3235","authenticated-orcid":false,"given":"Jocelyn","family":"Quistrebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiting","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6749-3426","authenticated-orcid":false,"given":"Marvin","family":"Reineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8366-2100","authenticated-orcid":false,"given":"Louise","family":"Benning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-0554","authenticated-orcid":false,"given":"Jonathan","family":"Honegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-8833","authenticated-orcid":false,"given":"Maike","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-4135","authenticated-orcid":false,"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7799-3045","authenticated-orcid":false,"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"STOPHCV investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane D.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Ala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Lye","family":"Ch\u2019ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wiselka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Forton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Halford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1386-3350","authenticated-orcid":false,"given":"Uta","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-8238","authenticated-orcid":false,"given":"Naglaa H.","family":"Shoukry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-9177","authenticated-orcid":false,"given":"Chaturaka","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-8887","authenticated-orcid":false,"given":"Andrew","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-3744","authenticated-orcid":false,"given":"Rowena A.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Azim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-7254","authenticated-orcid":false,"given":"Carolin","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McLauchlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"P\u00e9rez-del-Pulgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-7608","authenticated-orcid":false,"given":"Volker","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"67174_CR1","doi-asserted-by":"crossref","unstructured":"Hajarizadeh, B., Grebely, J. & Dore, G. J. Epidemiology and natural history of HCV infection. Nat. Rev. Gastroenterol. Hepatol 10, 553\u2013562 (2013).","DOI":"10.1038\/nrgastro.2013.107"},{"key":"67174_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"MP Manns","year":"2017","unstructured":"Manns, M. P. et al. Hepatitis C virus infection. Nat. Rev. Dis. Prim. 3, 17006 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"67174_CR3","unstructured":"WHO. Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries (World Health Organization, Geneva, 2024)."},{"key":"67174_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","volume":"9","author":"RH Wiesner","year":"2003","unstructured":"Wiesner, R. H., Sorrell, M. & Villamil, F. Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transplant. 9, S1\u2013S9 (2003).","journal-title":"Liver Transplant."},{"key":"67174_CR5","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/lt.22175","volume":"16","author":"TK Narang","year":"2010","unstructured":"Narang, T. K., Ahrens, W. & Russo, M. W. Post\u2013liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria. Liver Transplant. 16, 1228\u20131235 (2010).","journal-title":"Liver Transplant."},{"key":"67174_CR6","first-page":"454","volume":"29","author":"T Hori","year":"2016","unstructured":"Hori, T. et al. Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation. Ann. Gastroenterol. 29, 454\u2013459 (2016).","journal-title":"Ann. Gastroenterol."},{"key":"67174_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.cgh.2015.05.030","volume":"13","author":"V Leroy","year":"2015","unstructured":"Leroy, V. et al. Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation. Clin. Gastroenterol. Hepatol. 13, 1993\u20132001.e1992 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"67174_CR8","doi-asserted-by":"crossref","unstructured":"Forns, X. et al. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation. Hepatology 61, 1485\u20131494 (2015).","DOI":"10.1002\/hep.27681"},{"key":"67174_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1136\/gutjnl-2024-332177","volume":"73","author":"E Vo-Quang","year":"2024","unstructured":"Vo-Quang, E. & Pawlotsky, J.-M. Unusual\u2019 HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment. Gut 73, 1570\u20131582 (2024).","journal-title":"Gut"},{"key":"67174_CR10","doi-asserted-by":"publisher","first-page":"e1008271","DOI":"10.1371\/journal.pgen.1008271","volume":"15","author":"E Domingo","year":"2019","unstructured":"Domingo, E. & Perales, C. Viral quasispecies. PLOS Genet. 15, e1008271 (2019).","journal-title":"PLOS Genet."},{"key":"67174_CR11","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1084\/jem.20090766","volume":"207","author":"S Fafi-Kremer","year":"2010","unstructured":"Fafi-Kremer, S. et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med. 207, 2019\u20132031 (2010).","journal-title":"J. Exp. Med."},{"key":"67174_CR12","first-page":"167","volume":"369","author":"V Lohmann","year":"2013","unstructured":"Lohmann, V. Hepatitis C virus RNA replication. Curr. Top. Microbiol. Immunol. 369, 167\u2013198 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"67174_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann, V. et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110\u2013113 (1999).","journal-title":"Science"},{"key":"67174_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00430-018-0566-x","volume":"208","author":"V Lohmann","year":"2019","unstructured":"Lohmann, V. Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development. Med. Microbiol. Immunol. 208, 3\u201324 (2019).","journal-title":"Med. Microbiol. Immunol."},{"key":"67174_CR15","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","volume":"125","author":"T Kato","year":"2003","unstructured":"Kato, T. et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808\u20131817 (2003).","journal-title":"Gastroenterology"},{"key":"67174_CR16","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/JVI.77.5.3007-3019.2003","volume":"77","author":"V Lohmann","year":"2003","unstructured":"Lohmann, V., Hoffmann, S., Herian, U., Penin, F. & Bartenschlager, R. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J. Virol. 77, 3007\u20133019 (2003).","journal-title":"J. Virol."},{"key":"67174_CR17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"KJ Blight","year":"2000","unstructured":"Blight, K. J., Kolykhalov, A. A. & Rice, C. M. Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972\u20131974 (2000).","journal-title":"Science"},{"key":"67174_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI118025","volume":"96","author":"N Enomoto","year":"1995","unstructured":"Enomoto, N. et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.  J. Clin. Investig. 96, 224\u2013230 (1995).","journal-title":"J. Clin. Investig."},{"key":"67174_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199601113340203","volume":"334","author":"N Enomoto","year":"1996","unstructured":"Enomoto, N. et al. Mutations in the nonstructural protein 5a gene and response to interferon in patients with chronic Hepatitis C virus 1b infection. N. Engl. J. Med. 334, 77\u201382 (1996).","journal-title":"N. Engl. J. Med."},{"key":"67174_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature14899","volume":"524","author":"M Saeed","year":"2015","unstructured":"Saeed, M. et al. SEC14L2 enables pan-genotype HCV replication in cell culture. Nature 524, 471\u2013475 (2015).","journal-title":"Nature"},{"key":"67174_CR21","doi-asserted-by":"publisher","first-page":"e1010472","DOI":"10.1371\/journal.ppat.1010472","volume":"18","author":"C Heuss","year":"2022","unstructured":"Heuss, C. et al. A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo. PLOS Pathog. 18, e1010472 (2022).","journal-title":"PLOS Pathog."},{"key":"67174_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.antiviral.2018.07.014","volume":"158","author":"S Ramirez","year":"2018","unstructured":"Ramirez, S. & Bukh, J. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: essential tools in testing of antivirals and emerging vaccine strategies. Antivir. Res. 158, 264\u2013287 (2018).","journal-title":"Antivir. Res."},{"key":"67174_CR23","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"T Pietschmann","year":"2006","unstructured":"Pietschmann, T. et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103, 7408\u20137413 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67174_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1053\/j.gastro.2010.11.036","volume":"140","author":"TK Scheel","year":"2011","unstructured":"Scheel, T. K., Gottwein, J. M., Mikkelsen, L. S., Jensen, T. B. & Bukh, J. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha. Gastroenterology 140, 1032\u20131042 (2011).","journal-title":"Gastroenterology"},{"key":"67174_CR25","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1128\/JVI.00049-11","volume":"85","author":"JM Gottwein","year":"2011","unstructured":"Gottwein, J. M. et al. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A. J. Virol. 85, 8913\u20138928 (2011).","journal-title":"J. Virol."},{"key":"67174_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/jhep.2002.31770","volume":"35","author":"M Frese","year":"2002","unstructured":"Frese, M. et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694\u2013703 (2002).","journal-title":"Hepatology"},{"key":"67174_CR27","doi-asserted-by":"publisher","first-page":"13171","DOI":"10.1074\/jbc.RA119.009537","volume":"294","author":"M Dujardin","year":"2019","unstructured":"Dujardin, M. et al. Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication. J. Biol. Chem. 294, 13171\u201313185 (2019).","journal-title":"J. Biol. Chem."},{"key":"67174_CR28","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1128\/MCB.18.9.5208","volume":"18","author":"M Gale Jr.","year":"1998","unstructured":"Gale, M. Jr. et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell Biol. 18, 5208\u20135218 (1998).","journal-title":"Mol. Cell Biol."},{"key":"67174_CR29","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1128\/JVI.74.12.5587-5596.2000","volume":"74","author":"C Francois","year":"2000","unstructured":"Francois, C. et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74, 5587\u20135596 (2000).","journal-title":"J. Virol."},{"key":"67174_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1099\/jgv.0.001175","volume":"100","author":"M Gambato","year":"2019","unstructured":"Gambato, M. et al. Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation. J. Gen. Virol. 100, 63\u201368 (2019).","journal-title":"J. Gen. Virol."},{"key":"67174_CR31","doi-asserted-by":"publisher","first-page":"e23587","DOI":"10.1371\/journal.pone.0023587","volume":"6","author":"G Koutsoudakis","year":"2011","unstructured":"Koutsoudakis, G. et al. Cell culture replication of a genotype 1b Hepatitis C virus isolate cloned from a patient who underwent liver transplantation. PloS one 6, e23587 (2011).","journal-title":"PloS one"},{"key":"67174_CR32","doi-asserted-by":"publisher","first-page":"e0122975","DOI":"10.1371\/journal.pone.0122975","volume":"10","author":"I G\u00f6rzer","year":"2015","unstructured":"G\u00f6rzer, I. et al. Pre-transplant plasma torque teno virus load and increase dynamics after lung transplantation. PloS one 10, e0122975 (2015).","journal-title":"PloS one"},{"key":"67174_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/lt.25374","volume":"25","author":"P Ruiz","year":"2019","unstructured":"Ruiz, P. et al. Torque teno virus is associated with the state of immune suppression early after liver transplantation. Liver Transpl. 25, 302\u2013310 (2019).","journal-title":"Liver Transpl."},{"key":"67174_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jcp.2005.028126","volume":"59","author":"F Fenwick","year":"2006","unstructured":"Fenwick, F. et al. Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. J. Clin. Pathol. 59, 174\u2013178 (2006).","journal-title":"J. Clin. Pathol."},{"key":"67174_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jhep.2013.03.023","volume":"59","author":"L Mensa","year":"2013","unstructured":"Mensa, L. et al. Imaging of hepatitis C virus infection in liver grafts after liver transplantation. J. Hepatol. 59, 271\u2013278 (2013).","journal-title":"J. Hepatol."},{"key":"67174_CR36","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/ije\/dyw362","volume":"46","author":"J McLauchlan","year":"2017","unstructured":"McLauchlan, J. et al. Cohort profile: the hepatitis C virus (HCV) research UK clinical database and biobank. Int. J. Epidemiol. 46, 1391\u20131391h (2017).","journal-title":"Int. J. Epidemiol."},{"key":"67174_CR37","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep.26260","volume":"57","author":"K Esser-Nobis","year":"2013","unstructured":"Esser-Nobis, K. et al. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B. Hepatology 57, 953\u2013963 (2013).","journal-title":"Hepatology"},{"key":"67174_CR38","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.277.5325.570","volume":"277","author":"AA Kolykhalov","year":"1997","unstructured":"Kolykhalov, A. A. et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277, 570\u2013574 (1997).","journal-title":"Science"},{"key":"67174_CR39","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","volume":"94","author":"M Yanagi","year":"1997","unstructured":"Yanagi, M., Purcell, R. H., Emerson, S. U. & Bukh, J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a\u2009chimpanzee. Proc. Natl. Acad. Sci. USA 94, 8738\u20138743 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67174_CR40","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1128\/JVI.02667-09","volume":"84","author":"JM Gottwein","year":"2010","unstructured":"Gottwein, J. M. et al. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J. Virol. 84, 5277\u20135293 (2010).","journal-title":"J. Virol."},{"key":"67174_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2018.11.012","volume":"70","author":"R Costa","year":"2019","unstructured":"Costa, R. et al. SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations. J. Hepatol. 70, 603\u2013614 (2019).","journal-title":"J. Hepatol."},{"key":"67174_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1172\/JCI123623","volume":"130","author":"SL Coss","year":"2020","unstructured":"Coss, S. L. et al. CD4+ T cell restoration and control of hepatitis C virus replication after childbirth.  J. Clin. Investig. 130, 748\u2013753 (2020).","journal-title":"J. Clin. Investig."},{"key":"67174_CR43","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798\u2013801 (2009).","journal-title":"Nature"},{"key":"67174_CR44","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1053\/j.gastro.2015.07.043","volume":"149","author":"GR Foster","year":"2015","unstructured":"Foster, G. R. et al. Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. Gastroenterology 149, 1462\u20131470 (2015).","journal-title":"Gastroenterology"},{"key":"67174_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.12688\/wellcomeopenres.16594.2","volume":"6","author":"GS Cooke","year":"2021","unstructured":"Cooke, G. S. et al. Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. Wellcome Open Res 6, 93 (2021).","journal-title":"Wellcome Open Res"},{"key":"67174_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4254\/wjh.v10.i2.186","volume":"10","author":"VA Morozov","year":"2018","unstructured":"Morozov, V. A. & Lagaye, S. Hepatitis C virus: morphogenesis, infection and therapy. World J. Hepatol. 10, 186\u2013212 (2018).","journal-title":"World J. Hepatol."},{"key":"67174_CR47","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1002\/lt.21644","volume":"14","author":"S Ram\u00edrez","year":"2008","unstructured":"Ram\u00edrez, S., P\u00e9rez-Del-Pulgar, S. & Forns, X. Virology and pathogenesis of hepatitis C virus recurrence. Liver Transpl. 14, S27\u2013S35 (2008).","journal-title":"Liver Transpl."},{"key":"67174_CR48","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1053\/jlts.2003.50269","volume":"9","author":"GW McCaughan","year":"2003","unstructured":"McCaughan, G. W. & Zekry, A. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation. Liver Transplant. 9, S21\u2013S27 (2003).","journal-title":"Liver Transplant."},{"key":"67174_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/hep.1840210104","volume":"21","author":"PW Angus","year":"1995","unstructured":"Angus, P. W. et al. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 21, 14\u201318 (1995).","journal-title":"Hepatology"},{"key":"67174_CR50","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4254\/wjh.v14.i4.708","volume":"14","author":"R Kumar","year":"2022","unstructured":"Kumar, R. Review on hepatitis B virus precore\/core promoter mutations and their correlation with genotypes and liver disease severity. World J. Hepatol. 14, 708\u2013718 (2022).","journal-title":"World J. Hepatol."},{"key":"67174_CR51","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/ajt.15583","volume":"20","author":"N Kapila","year":"2020","unstructured":"Kapila, N., Al-Khalloufi, K., Bejarano, P. A., Vanatta, J. M. & Zervos, X. B. Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era. Am. J. Transplant. 20, 600\u2013605 (2020).","journal-title":"Am. J. Transplant."},{"key":"67174_CR52","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/gut.2003.031336","volume":"53","author":"M Pascu","year":"2004","unstructured":"Pascu, M. et al. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences. Gut 53, 1345\u20131351 (2004).","journal-title":"Gut"},{"key":"67174_CR53","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/hep.22543","volume":"48","author":"H Shirakawa","year":"2008","unstructured":"Shirakawa, H. et al. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology 48, 1753\u20131760 (2008).","journal-title":"Hepatology"},{"key":"67174_CR54","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jhep.2009.10.034","volume":"52","author":"T Fukuhara","year":"2010","unstructured":"Fukuhara, T. et al. Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. J. Hepatol. 52, 672\u2013680 (2010).","journal-title":"J. Hepatol."},{"key":"67174_CR55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.26205","volume":"58","author":"A El-Shamy","year":"2013","unstructured":"El-Shamy, A. et al. Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate With development of hepatocellular carcinoma. Hepatology 58, 555\u2013563 (2013).","journal-title":"Hepatology"},{"key":"67174_CR56","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2893.2006.00739.x","volume":"13","author":"T Kohashi","year":"2006","unstructured":"Kohashi, T. et al. Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication. J. Viral Hepat. 13, 582\u2013590 (2006).","journal-title":"J. Viral Hepat."},{"key":"67174_CR57","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1128\/JVI.76.6.2997-3006.2002","volume":"76","author":"M Ikeda","year":"2002","unstructured":"Ikeda, M., Yi, M., Li, K. & Lemon, S. M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76, 2997\u20133006 (2002).","journal-title":"J. Virol."},{"key":"67174_CR58","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1086\/319674","volume":"183","author":"H Watanabe","year":"2001","unstructured":"Watanabe, H. et al. Number and position of mutations in the interferon (IFN) sensitivity\u2013determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection.  J. Infect. Dis. 183, 1195\u20131203 (2001).","journal-title":"J. Infect. Dis."},{"key":"67174_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1099\/vir.0.81407-0","volume":"87","author":"S Liu","year":"2006","unstructured":"Liu, S., Ansari, I. H., Das, S. C. & Pattnaik, A. K. Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. J. Gen. Virol. 87, 323\u2013327 (2006).","journal-title":"J. Gen. Virol."},{"key":"67174_CR60","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/acsinfecdis.6b00143","volume":"2","author":"M Ngure","year":"2016","unstructured":"Ngure, M. et al. Interactions of the disordered domain II of Hepatitis C virus NS5A with cyclophilin A, NS5B, and viral RNA show extensive overlap. ACS Infect. Dis. 2, 839\u2013851 (2016).","journal-title":"ACS Infect. Dis."},{"key":"67174_CR61","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1074\/jbc.M111392200","volume":"277","author":"Y Shirota","year":"2002","unstructured":"Shirota, Y. et al. Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J. Biol. Chem. 277, 11149\u201311155 (2002).","journal-title":"J. Biol. Chem."},{"key":"67174_CR62","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1074\/jbc.M117.813766","volume":"292","author":"LM Bessa","year":"2017","unstructured":"Bessa, L. M. et al. NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B. J. Biol. Chem. 292, 18024\u201318043 (2017).","journal-title":"J. Biol. Chem."},{"key":"67174_CR63","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/j.healun.2023.02.470","volume":"42","author":"A Plana","year":"2023","unstructured":"Plana, A., Belkin, M. & Grinstein, J. (455) acute liver injury as a complication of heart transplant from a hepatitis C+ donor.  J. Heart Lung Transplant. 42, S210 (2023).","journal-title":"J. Heart Lung Transplant."},{"key":"67174_CR64","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ajt.2023.10.006","volume":"24","author":"W Aleyadeh","year":"2024","unstructured":"Aleyadeh, W. et al. Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study. Am. J. Transplant. 24, 468\u2013478 (2024).","journal-title":"Am. J. Transplant."},{"key":"67174_CR65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/PAS.0000000000000345","volume":"39","author":"AT Evans","year":"2015","unstructured":"Evans, A. T. et al. Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.  Am. J. Surg. Pathol. 39, 212\u2013220 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"67174_CR66","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1572-0241.2002.05459.x","volume":"97","author":"PM Rosenberg","year":"2002","unstructured":"Rosenberg, P. M. et al. Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection.  Am. J. Gastroenterol. 97, 478\u2013483 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"67174_CR67","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S1665-2681(19)30773-2","volume":"14","author":"AM Pellicelli","year":"2015","unstructured":"Pellicelli, A. M. et al. Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma. Ann. Hepatol. 14, 756\u2013761 (2015).","journal-title":"Ann. Hepatol."},{"key":"67174_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2893.2007.00892.x","volume":"15","author":"CH Hung","year":"2008","unstructured":"Hung, C. H. et al. Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma. J. Viral Hepat. 15, 58\u201365 (2008).","journal-title":"J. Viral Hepat."},{"key":"67174_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/jhep.2001.25512","volume":"34","author":"M Gim\u00e9nez-Barcons","year":"2001","unstructured":"Gim\u00e9nez-Barcons, M. et al. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b\u2013related cirrhosis. Hepatology 34, 158\u2013167 (2001).","journal-title":"Hepatology"},{"key":"67174_CR70","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399\u2013401 (2009).","journal-title":"Nature"},{"key":"67174_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25218-x","volume":"12","author":"Q Chen","year":"2021","unstructured":"Chen, Q. et al. Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses. Nat. Commun. 12, 4882 (2021).","journal-title":"Nat. Commun."},{"key":"67174_CR72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000539646","volume":"18","author":"H Wilson","year":"2024","unstructured":"Wilson, H., Macdonald, D. & Bryce, K. Clearance of Hepatitis C virus following immune checkpoint inhibitor therapy for hepatocellular carcinoma: case report. Case Rep. Gastroenterol. 18, 347\u2013351 (2024).","journal-title":"Case Rep. Gastroenterol."},{"key":"67174_CR73","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1432-2277.2002.tb00183.x","volume":"15","author":"PJ Gow","year":"2002","unstructured":"Gow, P. J. & Mutimer, D. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency. Transpl. Int. 15, 380\u2013383 (2002).","journal-title":"Transpl. Int."},{"key":"67174_CR74","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000480","volume":"94","author":"DL Li","year":"2015","unstructured":"Li, D. L., Fang, J., Zheng, Z., Wu, W. & Wu, Z. Successful treatment of fibrosing cholestatic hepatitis following kidney transplantation with allogeneic hematopoietic stem cell transplantation: a case report. Medicine 94, e480 (2015).","journal-title":"Medicine"},{"key":"67174_CR75","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1093\/cid\/ciad336","volume":"77","author":"TJ Liang","year":"2023","unstructured":"Liang, T. J. et al. Challenge inoculum for hepatitis C virus controlled human infection model. Clin. Infect. Dis. 77, S257\u2013S261 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"67174_CR76","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jvh.12701","volume":"24","author":"EB Cunningham","year":"2017","unstructured":"Cunningham, E. B. et al. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: the HITS-p study. J. Viral Hepat. 24, 733\u2013741 (2017).","journal-title":"J. Viral Hepat."},{"key":"67174_CR77","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrgastro.2017.106","volume":"14","author":"J Grebely","year":"2017","unstructured":"Grebely, J., Hajarizadeh, B. & Dore, G. J. Direct-acting antiviral agents for HCV infection affecting people who inject drugs. Nat. Rev. Gastroenterol. Hepatol. 14, 641\u2013651 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"67174_CR78","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"67174_CR79","doi-asserted-by":"crossref","first-page":"11.10.11","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high-confidence variant calls: the genome analysis Toolkit best practices pipeline. Curr. Protoc. Bioinforma. 43, 11.10.11\u201311.10.33 (2013).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"67174_CR80","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"67174_CR81","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1089\/106652702761034136","volume":"9","author":"R Desper","year":"2002","unstructured":"Desper, R. & Gascuel, O. Fast and accurate phylogeny reconstruction algorithms based on the minimum-evolution principle. J. Comput. Biol. 9, 687\u2013705 (2002).","journal-title":"J. Comput. Biol."},{"key":"67174_CR82","doi-asserted-by":"publisher","first-page":"D593","DOI":"10.1093\/nar\/gkr859","volume":"40","author":"BE Pickett","year":"2012","unstructured":"Pickett, B. E. et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 40, D593\u2013D598 (2012).","journal-title":"Nucleic Acids Res."},{"key":"67174_CR83","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1128\/JVI.02144-06","volume":"81","author":"T Schaller","year":"2007","unstructured":"Schaller, T. et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J. Virol. 81, 4591\u20134603 (2007).","journal-title":"J. Virol."},{"key":"67174_CR84","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463\u20138471 (1998).","journal-title":"J. Virol."},{"key":"67174_CR85","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1128\/JVI.02460-05","volume":"80","author":"G Koutsoudakis","year":"2006","unstructured":"Koutsoudakis, G. et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80, 5308\u20135320 (2006).","journal-title":"J. Virol."},{"key":"67174_CR86","doi-asserted-by":"publisher","first-page":"e50859","DOI":"10.1371\/journal.pone.0050859","volume":"7","author":"J Vermeire","year":"2012","unstructured":"Vermeire, J. et al. Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. PloS One 7, e50859 (2012).","journal-title":"PloS One"},{"key":"67174_CR87","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/bioinformatics\/btv494","volume":"31","author":"U Bodenhofer","year":"2015","unstructured":"Bodenhofer, U., Bonatesta, E., Horej\u0161-Kainrath, C. & Hochreiter, S. msa: an R package for multiple sequence alignment. Bioinformatics 31, 3997\u20133999 (2015).","journal-title":"Bioinformatics"},{"key":"67174_CR88","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. & Barton, G. J. Jalview Version 2\u2014a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189\u20131191 (2009).","journal-title":"Bioinformatics"},{"key":"67174_CR89","doi-asserted-by":"publisher","first-page":"W636","DOI":"10.1093\/nar\/gkz268","volume":"47","author":"F Madeira","year":"2019","unstructured":"Madeira, F. et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 47, W636\u2013W641 (2019).","journal-title":"Nucleic Acids Res."},{"key":"67174_CR90","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng.3835","volume":"49","author":"MA Ansari","year":"2017","unstructured":"Ansari, M. A. et al. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nat. Genet. 49, 666\u2013673 (2017).","journal-title":"Nat. Genet."},{"key":"67174_CR91","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses.  Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"67174_CR92","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"67174_CR93","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1093\/bioinformatics\/btz567","volume":"35","author":"SM Gogarten","year":"2019","unstructured":"Gogarten, S. M. et al. Genetic association testing using the GENESIS R\/Bioconductor package. Bioinformatics 35, 5346\u20135348 (2019).","journal-title":"Bioinformatics"},{"key":"67174_CR94","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","volume":"28","author":"X Zheng","year":"2012","unstructured":"Zheng, X. et al. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 28, 3326\u20133328 (2012).","journal-title":"Bioinformatics"},{"key":"67174_CR95","doi-asserted-by":"crossref","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, s13742-015 (2015).","DOI":"10.1186\/s13742-015-0047-8"},{"key":"67174_CR96","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/ije\/dys167","volume":"42","author":"J Grebely","year":"2013","unstructured":"Grebely, J. et al. Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int. J. Epidemiol. 42, 1649\u20131659 (2013).","journal-title":"Int. J. Epidemiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67174-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:04:19Z","timestamp":1765584259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67174-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["67174"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67174-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6194507\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10948"}}